Similarly, although overexpression of the cell cycle regulator MYC and the anti-apoptosis protein BCL2 has prognostic value in the systemic diffuse large B-cell lymphoma, their significance in PCNLS remains uncertain [19]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.